AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion
Jun 30, 2025 5:58 AM
08:43 AM EDT, 06/30/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that it has agreed to acquire clinical-stage biotechnology company Capstan Therapeutics.
AbbVie ( ABBV ) said it will pay up to $2.1 billion in cash at closing.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.